… COVID-19 vaccine trials”. Out of which 52 were full texts of clinical trials assessing the safety
of COVID-19 vaccines… of eleven clinical trials on COVID-19 vaccines were published [3]. The …

… In addition, no serious safety signals have been reported from initial phase 1 trials of
COVID-19 vaccine candidates, with the caveat that the number of vaccinees who have been …

… , and reliable evaluation of many candidate vaccines against COVID-19. There is a danger
… introduction of a COVID-19 vaccine could lead to widespread deployment of a vaccine that is …

… of COVID-19 vaccines will seriously affect the ongoing phases 2 and 3 randomised
placebo-controlled trials assessing SARS-CoV-2 vaccine … and future trials of other COVID-19 …

… of COVID-19 vaccine efficacy in clinical trials by several … for the next steps to ensure vaccination
of the global population is … doses of high-quality vaccines, support for vaccine purchase, …

… on study endpoints in COVID-19 vaccine efficacy trials. First, … comparison of the efficacy of
vaccine candidates, overall and … COVID-19 as well as assessment of the longer-term vaccine …

… -CoV2373 vaccine candidate or other COVID-19 vaccines in African … trial, also led by Madhi,
of a COVID-19 vaccine in South Africa commenced on June 23, which was the first vaccine …

… A 69-year old receives a COVID-19 vaccine in a Phase 3 trial. It is important to understand
how different groups respond to COVID-19 vaccines to establish the most effective …

… Although much of this focus is on trials in the United States, the COVID-19 Prevention
Networks established under the ACTIV program have a global focus, and coordination with the …

… Possible end points for consideration in COVID-19 vaccine trials include clinical disease of
… the trial population is of key importance for advanced-stage COVID-19 vaccine trials. The …